Mitochondrial Diseases: Clinical Trials

456 trials for Mitochondrial Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

254 completed, 74 recruiting, 34 unknown, 21 active not recruiting. 111 Phase 2, 98 Not applicable, 66 Phase 1, 46 Phase 3, 15 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2111Completed 71, Recruiting 11, Terminated 9, Withdrawn 6, Unknown 5, Active not recruiting 4, Not yet recruiting 3, Enrolling by invitation 1, Suspended 1
Not applicable98Completed 58, Unknown 12, Recruiting 11, Not yet recruiting 7, Active not recruiting 5, Terminated 3, Enrolling by invitation 2
Phase 166Completed 39, Recruiting 9, Terminated 6, Active not recruiting 4, Not yet recruiting 4, Unknown 2, Withdrawn 2
Phase 346Completed 25, Recruiting 7, Active not recruiting 5, Terminated 4, Not yet recruiting 2, Withdrawn 2, Unknown 1
Phase 415Completed 12, Unknown 2, Terminated 1
Early Phase 14Completed 4

Follow Mitochondrial Diseases: new trials by email Literature Review of Mitochondrial Diseases trials Research Report on Mitochondrial Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)
Phase 1 / Phase 2Not yet recruitingGeorge Washington University242027-03-012026-10-05
Role of AMPKalpha2 in Myonuclear Accretion in Mitochondrial Myopathies
Analysis of signaling pathway : AMPK - MItochondrial Myopathies
Not yet recruitingHospices Civils de Lyon122027-01-012026-11-05
Efficacy and Safety of Modafinil to Treat Fatigue in People With Mitochondrial Disease.
Modafinil (M), Placebo - Mitochondrial Disease
Phase 3Not yet recruitingKenneth Myers, MD152026-12-012026-10-26
GV101 for Friedreich's Ataxia (FA) Treatment
GV101, Placebo - Friedreich's Ataxia
Phase 2Not yet recruitingGraviton Bioscience Corporation482026-11-012026-10-15
The Precision Mito- Mito Map COMPASS Study
Mito Map Energy Score and Home Functional Assessments - Mitochondrial Diseases, Myalgic Encephalomyelitis Chronic Fatigue Syndrome
Not yet recruitingAI Agent Vault, Inc. d/b/a Precision Mito4002026-11-012026-10-02
A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia
Nomlabofusp, Placebo - Friedreich Ataxia, Friedreich's Ataxia
Phase 3RecruitingLarimar Therapeutics, Inc.1502026-10-262026-10-09
A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies
Omaveloxolone - Friedreich Ataxia
RecruitingBiogen102026-10-262026-07-10
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy Adults
ATI-105, Placebo - Friedreich Ataxia, Cardiomyopathies
Phase 1Not yet recruitingAdjuvia Therapeutics, Inc.602026-10-262026-10-09
A Study to Learn More About Friedrich's Ataxia in People Living in the Gulf Cooperation Council (GCC) Region of the World
Friedreich's Ataxia
Not yet recruitingBiogen402026-10-152026-10-21
Natural History of MADD
Multiple Acyl-CoA Dehydrogenase Deficiency
RecruitingIcahn School of Medicine at Mount Sinai502026-10-012026-09-16
A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS)
TTI-0102: cysteamine-pantetheine disulfide, D-Mannitol - Leigh Syndrome
Phase 2Not yet recruitingThiogenesis Therapeutics, Inc.182026-10-012026-07-24
Mitigating Mitochondrial RNA Release During Aging to Control Inflammation and Senescence
Skin biopsy and venous blood sampling - Aging, Inflammation
Not applicableNot yet recruitingMario Negri Institute for Pharmacological Research902026-09-012026-05-19
MItochondrial Intervention for Resilience in Older Adults With Coenzyme Q10
Q10Vital® (CoQ10, ubiquinone), Placebo - Frailty, Aging
Not applicableNot yet recruitingUniversity Medical Centre Ljubljana1002026-09-012026-08-19
Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)
Vatiquinone - Friedreich's Ataxia
Phase 3Not yet recruitingPTC Therapeutics1202026-08-152026-08-14
Validation of the Snouda Metabolic Score for Phenotyping and Guiding Reversal in Type 2 Diabetes
Phenotype-Matched Dietary Protocol, Structured Progressive Exercise Protocol, Targeted Nutritional Supplementation - Type 2 Diabetes Mellitus (T2DM), Insulin Resistance
Not applicableEnrolling by invitationSalah Snouda1502026-08-012026-08-18
Digital Outcome Assessment Using AI Active Gaming and Motion Capture in Friedreich Ataxia
Laboratory validation session (VSimulator), Home-based active gaming assessment - Friedreich Ataxia
Not yet recruitingUniversity of Exeter402026-07-302026-07-28
A Longitudinal Natural History Study of OPA1-Associated Autosomal-Dominant Optic Atrophy
OPA1 Gene Mutation, Optic Atrophy, Autosomal Dominant
RecruitingLudwig-Maximilians - University of Munich502026-07-162026-07-28
Cardiac Output and Fatigue in Friedreich's Ataxia
Aerobic Exercise - Friedreich's Ataxia
Not applicableRecruitingScott Barbuto302026-07-152026-09-22
Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
LX2006, Usual Care - Friedreich Ataxia, Cardiomyopathy, Secondary
Phase 2RecruitingLexeo Therapeutics262026-06-252026-09-02
Metabolic and Functional Study of γδ T Cells in Critically Ill Patients
Sepsis, Critical Illness
RecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology1052026-06-212026-10-27

Showing 20 of 456. Sign in to see all of them.

Narrower conditions

Friedreich Ataxia (110)  ·  Multiple Acyl Coenzyme A Dehydrogenase Deficiency (60)  ·  Optic Atrophy, Hereditary, Leber (44)  ·  Mitochondrial Myopathies (42)  ·  HIV Infections (41)  ·  Cytomegalovirus Infections (39)  ·  Acquired Immunodeficiency Syndrome (37)  ·  MELAS Syndrome (37)  ·  Cytomegalovirus Retinitis (30)  ·  Retinitis (25)  ·  AIDS-Related Opportunistic Infections (20)  ·  Leigh Disease (20)  ·  Ataxia (13)  ·  Genetic Diseases, Inborn (13)

Broader conditions

Nutritional and Metabolic Diseases (455)  ·  Metabolic Diseases (452)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (306)  ·  Nervous System Diseases (296)  ·  Genetic Diseases, Inborn (293)  ·  Central Nervous System Diseases (202)  ·  Brain Diseases (196)  ·  Heredodegenerative Disorders, Nervous System (179)  ·  Neurodegenerative Diseases (169)  ·  Metabolism, Inborn Errors (132)  ·  Spinal Cord Diseases (116)  ·  Cerebellar Diseases (110)  ·  Pathological Conditions, Signs and Symptoms (108)  ·  Spinocerebellar Degenerations (108)

Interventions

Ganciclovir (44)  ·  alpha-tocotrienol quinone (16)  ·  idebenone (15)  ·  Blood Specimen Collection (11)  ·  Valganciclovir (9)  ·  Foscarnet (8)  ·  omaveloxolone (7)  ·  arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide (6)  ·  coenzyme Q10 (6)  ·  Exercise (5)  ·  6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (4)  ·  Arginine (4)  ·  Magnetic Resonance Spectroscopy (4)  ·  Resveratrol (4)  ·  Ubiquinone (4)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (22)  ·  Children's Hospital of Philadelphia (14)  ·  Hoffmann-La Roche (12)  ·  Santhera Pharmaceuticals (12)  ·  Centre Hospitalier Universitaire de Nice (10)  ·  PTC Therapeutics (10)  ·  Copenhagen University Hospital, Rigshospitalet (9)  ·  GenSight Biologics (8)  ·  Larimar Therapeutics, Inc. (8)  ·  Biogen (7)  ·  Columbia University (7)  ·  Khondrion BV (6)  ·  Stealth BioTherapeutics Inc. (6)  ·  University of South Florida (6)  ·  Amgen (5)

Countries

United States (242)  ·  France (67)  ·  Italy (49)  ·  Germany (46)  ·  United Kingdom (44)  ·  Canada (32)  ·  Spain (30)  ·  Netherlands (28)  ·  Australia (25)  ·  Belgium (22)  ·  Denmark (22)  ·  Austria (16)  ·  Brazil (10)  ·  China (10)  ·  New Zealand (7)

Top investigators

Michio Hirano, MD (6)  ·  David Lynch, MD, PhD (4)  ·  David Lynch, MD (3)  ·  John Vissing, MD (3)  ·  Magdy Shenouda, M.D. (3)  ·  Matteo Fiorenza, Ph.D. (3)  ·  Amel Karaa, MD (2)  ·  Arnold Munnich, M.D. (2)  ·  David Lynch, MD PhD (2)  ·  Hardy WD (2)  ·  MA Jacobson (2)

Results publications

PMID 36449262, PMID 34108929, PMID 40739200, PMID 17562928, PMID 21779958, PMID 21788663, PMID 26606867, PMID 26892229, PMID 33246973, PMID 34645790, PMID 38700045, PMID 39807668, PMID 42307907, PMID 11182283, PMID 11972582, PMID 12013896, PMID 12508073, PMID 12771225, PMID 12826641, PMID 1463007, PMID 14661862, PMID 15090651, PMID 15498605, PMID 15684706, PMID 16267188, PMID 16621917, PMID 1674640, PMID 16801664, PMID 16849828, PMID 16900450, PMID 16971696, PMID 16971699, PMID 17080429, PMID 17287825, PMID 17353390, PMID 17483096, PMID 17486094, PMID 17502776, PMID 17549623, PMID 17826341, PMID 18238797, PMID 18414145, PMID 18441370, PMID 18441371, PMID 18467430, PMID 18546365, PMID 18725595, PMID 18774912, PMID 19103785, PMID 19125351

NIH funding

2025 (5), U54NS078059 (5), 2018 (4), 2017 (3), 2015 (2), P01HD032062 (2), R01AR083552 (2), 2008 (1), 2019 (1), 2023 (1), K01HD084690 (1), K23AI070078 (1), K23MH077287 (1), N01AI30025 (1), R01AG034995 (1)